![](/img/cover-not-exists.png)
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents
Wenjie Jessie Lu, Cong Xu, Zifan Pei, Abdelrahman S. Mayhoub, Mark Cushman, David A. FlockhartVolume:
133
Language:
english
Pages:
11
DOI:
10.1007/s10549-011-1699-4
Date:
May, 2012
File:
PDF, 577 KB
english, 2012